Compare LFUS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFUS | RGEN |
|---|---|---|
| Founded | 1927 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.6B |
| IPO Year | 1996 | 1995 |
| Metric | LFUS | RGEN |
|---|---|---|
| Price | $405.95 | $116.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $366.67 | $167.67 |
| AVG Volume (30 Days) | 198.4K | ★ 817.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $757,853,000.00 | $141,236,000.00 |
| Revenue This Year | $14.65 | $14.30 |
| Revenue Next Year | $6.98 | $14.52 |
| P/E Ratio | ★ N/A | $131.21 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $174.63 | $109.50 |
| 52 Week High | $404.80 | $175.77 |
| Indicator | LFUS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 72.82 | 42.86 |
| Support Level | $249.00 | $111.29 |
| Resistance Level | N/A | $131.93 |
| Average True Range (ATR) | 9.69 | 6.15 |
| MACD | 2.51 | -0.27 |
| Stochastic Oscillator | 94.79 | 23.16 |
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. The company is also increasing its power semiconductor business, where it predominantly serves industrial end markets, and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.